Who owns Autolus Therapeutics plc? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Autolus Therapeutics plc in our court records and SEC 8-K records (as of 2026-10-18).
• Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-04-29).
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ppf Group A.S. (filed 2026-08-28).

Who is behind it

Autolus Therapeutics plc: business address in London, X0; industry Biological Products, (No Diagnostic Substances) (Schedule 13D/A, 2026-08-28).

Officers and directors, each with the role and the filing that names them:

• Christian Itin: Executive Officer, Director (Form D, 2024-02-23)
• Robert Dolski: Executive Officer (Form D, 2024-02-23)
• Edgar Braendle: Executive Officer (Form D, 2024-02-23)
• David Brochu: Executive Officer (Form D, 2024-02-23)
• Martin Pule: Executive Officer (Form D, 2024-02-23)
• Christopher Vann: Executive Officer (Form D, 2024-02-23)
• Brent Rice: Executive Officer (Form D, 2024-02-23)
• John H. Johnson: Director (Form D, 2024-02-23)
• Joseph Anderson: Director (Form D, 2024-02-23)
• Robert Azelby: Director (Form D, 2024-02-23)
• Linda Bain: Director (Form D, 2024-02-23)
• John Berriman: Director (Form D, 2024-02-23)

Money raised

Latest IPO step: Autolus Therapeutics plc filed to go public (S-1, 2025-05-08).

IPO filings: S-1, 2025-05-08.

Red flags found

1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-04-29).

Related pages

Layoffs5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.